CJ Biomaterials

Supplier

Summarized by Halo AI

CJ Biomaterials develops and manufactures sustainable, bio-based polyhydroxyalkanoate (PHA) biopolymers. Its products offer biodegradable and compostable alternatives to fossil fuel-based plastics for use in packaging, agriculture, and other industries.

Company size

Less than 500 employees

Portfolio summary

PHACT brand polyhydroxyalkanoate (PHA) biopolymers, including neat resins, masterbatches, and customized compounding blends, such as amorphous PHA, designed for compostable packaging, film, coatings, and consumer applications.

Markets served

APAC · NA · EMEA

Manufacturing locations

A polyhydroxyalkanoate (PHA) manufacturing facility with a 5,000-metric-ton capacity located in Pasuruan, Indonesia.

R&D locations

Suwon, South Korea (CJ Blossom Park) · Woburn, MA, USA (Polymer science, testing, and applications facility)

CJ Biomaterials develops bio-based chemicals and biopolymers, focusing on creating sustainable, circular solutions to replace fossil fuel-based plastics and chemicals, and is a global leader in PHA biopolymer manufacturing.

AI summary generated on Jun 22, 2026

OpenAlex

For general inquiries

Ben Neisen

Business Development Manager

Is this page yours? Boost its visibility

List technologies, facilities, services, or grant collaboration opportunities.

CJ Biomaterials

For general inquiries

Key links